Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past
decade, have shown promising results in decreasing HPV infection and related diseases …

Minority youth represent a unique population for public health interventions given the social,
economic, and cultural barriers they often face in accessing health services. Interventions to …

Background Racial and ethnic variations in attribution of cervical precancer and cancer to
human papillomavirus (HPV) types may result in different HPV vaccine protection, screening …

Importance Rates of human papillomavirus (HPV) infection have decreased since the
introduction of HPV vaccines in populations with high vaccine uptake. Data are limited for …

Human papillomavirus (HPV) contributes to sexually transmitted infection, which is primarily
associated with pre-cancerous and cancerous lesions in both men and women and is …

Introduction Vaccine effectiveness and impact studies are typically observational, generating
evidence after vaccine launch in a real-world setting. For human papillomavirus (HPV) …

Background: High-risk human papillomavirus (hrHPV) testing is utilized in primary cervical
cancer screening, generally along with cytology, to triage abnormalities to colposcopy. Most …

Drug treatment courts (DTC) address substance use disorders (SUD) but not cooccurrencing
HIV or hepatitis C virus (HCV). This pilot explored feasibility and preliminary outcomes of the …

Importance While minorities represent around 20% of all HNC patients, these demographics
are largely understudied. Furthermore, trends in national studies may not always be fully …

Persistent infection with high-risk human papillomavirus (HPV) is the cause of most cervical
cancers (1, 2). Over the past decades, there has been significant progress in primary and …